Glasdegib tablets combined with low-dose cytarabine is a standardized regimen for the treatment of newly diagnosed acute myeloid leukemia (AML)...
Glasdegib film is a targeted drug used to treat newly diagnosed acute myeloid leukemia (AML), which requires combination with low-dose cytarabi...
The side effects of Tasfigo succinate involve multiple systemic reactions and require differentiated management measures based on severity. The...
Tasfigo succinate is a novel tyrosine kinase inhibitor that exerts anti-tumor effects by targeting FGFR1/2/3, mainly used for the treatment of ...
Tasfigo succinate is an anti-tumor drug targeting FGFR1/2/3, mainly used to treat biliary cancer patients with FGFR2 gene abnormalities. The fo...
Betamethasone, as an ATP citrate lyase inhibitor, significantly reduces LDL-C levels by blocking the upstream pathway of cholesterol synthesis,...
Nexletol is an innovative oral medication for treating hypercholesterolemia, which reduces LDL-C by inhibiting ATP citrate lyase. The standard ...
Nexletol is a novel oral cholesterol lowering drug, particularly suitable for patients with statin intolerance. As an ATP citrate lyase inhibit...
Nexletol is an oral medication used to treat hypercholesterolemia, which reduces low-density lipoprotein cholesterol (LDL-C) by inhibiting ATP ...
Saphnelo is an FDA approved type I interferon receptor antagonist for moderate to severe systemic lupus erythematosus (SLE), with a standard do...